COPD readmission may be tied to unmodifiable risk factors

October 22, 2012

National efforts are underway to reduce 30-day readmission for chronic obstructive pulmonary disease (COPD); however, new research suggests that COPD readmissions may be related to risk factors that cannot be modified, including advanced disease and psychosocial factors.

Researchers from the University of Texas Medical Branch in Galveston performed a retrospective chart review of all patients with primary discharge diagnosis of COPD. Of the 160 patients admitted for a total of 193 hospitalizations, 30 patients were readmitted within 30 days. Patients who were readmitted were more likely to be black, had , , history of alcohol abuse, and were using supplemental oxygen. There was no difference in baseline medication use, length of stay, or serum bicarbonate values, and whether or not the patient had a follow-up postdischarge.

In a multivariate analysis, odds of 30-day readmission was 2.56 in patients using supplemental oxygen, and 2.17 in patients with alcohol abuse. Researchers conclude that 30-day readmission in patients with COPD was related to advanced disease and that are unlikely to be modifiable. This study was presented during CHEST 2012, the annual meeting of the , held October 20 – 25, in Atlanta, Georgia.

Explore further: Hospital readmission rates not accurate measure of care quality

Related Stories

Recommended for you

The 'love hormone' may quiet tinnitus

September 23, 2016

(HealthDay)—People suffering from chronic ringing in the ears—called tinnitus—may find some relief by spraying the hormone oxytocin in their nose, a small initial study by Brazilian researchers suggests.

Bile acid uptake inhibitor prevents NASH / fatty liver in mice

September 21, 2016

Drugs that interfere with bile acid recycling can prevent several aspects of NASH (nonalcoholic steatohepatitis) in mice fed a high-fat diet, scientists from Emory University School of Medicine and Children's Healthcare of ...

New therapeutic target for Crohn's disease

September 20, 2016

Research from the Sanford Burnham Prebys Medical Discovery Institute (SBP) identifies a promising new target for future drugs to treat inflammatory bowel disease (IBD). The study, published today in Cell Reports, also indicates ...

Arthritis drug may help with type of hair loss

September 22, 2016

(HealthDay)—For people who suffer from a condition that causes disfiguring hair loss, a drug used for rheumatoid arthritis might regrow their hair, a new, small study suggests.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.